Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Carolina Gemma(Hammersmith Hospital), Simak Ali(The London College)
Cited by 10
Related Papers
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases
|Nucleic Acids Research|2006|107
Estrogen Receptor α/14-3-3 molecular glues as alternative treatment strategy for endocrine resistant breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2024|5